IN2012DN06571A - - Google Patents

Info

Publication number
IN2012DN06571A
IN2012DN06571A IN6571DEN2012A IN2012DN06571A IN 2012DN06571 A IN2012DN06571 A IN 2012DN06571A IN 6571DEN2012 A IN6571DEN2012 A IN 6571DEN2012A IN 2012DN06571 A IN2012DN06571 A IN 2012DN06571A
Authority
IN
India
Prior art keywords
bonj
patients
bisphosphonate
methods
genetic
Prior art date
Application number
Other languages
English (en)
Inventor
Joseph Katz
Taimour Y Langaee
Original Assignee
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida filed Critical Univ Florida
Publication of IN2012DN06571A publication Critical patent/IN2012DN06571A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/172Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN6571DEN2012 2010-01-06 2010-12-13 IN2012DN06571A (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29273010P 2010-01-06 2010-01-06
PCT/US2010/060139 WO2011084387A2 (en) 2010-01-06 2010-12-13 Methods and kits for detecting risk factors for development of jaw osteonecrosis and methods of treatment thereof

Publications (1)

Publication Number Publication Date
IN2012DN06571A true IN2012DN06571A (https=) 2015-10-23

Family

ID=44306025

Family Applications (1)

Application Number Title Priority Date Filing Date
IN6571DEN2012 IN2012DN06571A (https=) 2010-01-06 2010-12-13

Country Status (9)

Country Link
US (1) US20130035314A1 (https=)
EP (1) EP2521793A4 (https=)
CN (1) CN102812132A (https=)
AU (1) AU2010340161A1 (https=)
BR (1) BR112012016744A2 (https=)
CA (1) CA2786545A1 (https=)
IN (1) IN2012DN06571A (https=)
RU (1) RU2012133434A (https=)
WO (1) WO2011084387A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010005939A1 (en) * 2008-07-07 2010-01-14 University Of Florida Research Foundation, Inc. Methods and kits for detecting risk factors for development of jaw osteonecrosis and methods of treatment thereof
WO2015083163A1 (en) * 2013-12-04 2015-06-11 Micromedic Technologies Ltd. Methods and kits for identifying susceptability to antiresorptive-agent-induced osteonecrosis of the jaw
CN111518882B (zh) * 2019-02-03 2022-06-28 陈卫衡 通过分子标志物辨识激素性股骨头坏死的中医证型的系统
CN112410413A (zh) * 2020-09-24 2021-02-26 吉林大学 Onfh易感相关vdr、mmp2、mmp3、mmp9基因snp的检测物质及应用
ES2994026A1 (es) * 2023-07-11 2025-01-16 Fundacion Instituto De Investig Sanitaria De Santiago De Compostela Metodo in vitro para identificar si un sujeto tratado con agentes modificadores de los huesos puede desarrollar osteonecrosis de los maxilares

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003062465A1 (es) * 2002-01-25 2003-07-31 Universidad De Barcelona Compuestos para el diagnóstico de la predisposición a la osteoporosis
WO2010005939A1 (en) * 2008-07-07 2010-01-14 University Of Florida Research Foundation, Inc. Methods and kits for detecting risk factors for development of jaw osteonecrosis and methods of treatment thereof

Also Published As

Publication number Publication date
CA2786545A1 (en) 2011-07-14
RU2012133434A (ru) 2014-02-27
EP2521793A4 (en) 2013-07-03
AU2010340161A1 (en) 2012-07-26
US20130035314A1 (en) 2013-02-07
EP2521793A2 (en) 2012-11-14
BR112012016744A2 (pt) 2017-06-13
WO2011084387A2 (en) 2011-07-14
WO2011084387A3 (en) 2011-10-27
CN102812132A (zh) 2012-12-05

Similar Documents

Publication Publication Date Title
Vijai et al. A genome-wide association study of marginal zone lymphoma shows association to the HLA region
Chou et al. Replication of association of IL1 gene complex members with ankylosing spondylitis in Taiwanese Chinese
Lambrot et al. Whole-genome sequencing of H3K4me3 and DNA methylation in human sperm reveals regions of overlap linked to fertility and development
Gunasekara et al. Systemic interindividual epigenetic variation in humans is associated with transposable elements and under strong genetic control
NZ590832A (en) Genetic variants for schizophrenia risk assessment
Sugawara et al. DNA methylation analyses of the candidate genes identified by a methylome‐wide association study revealed common epigenetic alterations in schizophrenia and bipolar disorder
Schulze et al. Loci on chromosomes 6q and 6p interact to increase susceptibility to bipolar affective disorder in the national institute of mental health genetics initiative pedigrees
Castagnola et al. Uncovering forensic evidence: a path to age estimation through DNA methylation
Guan et al. Association study of a new schizophrenia susceptibility locus of 10q24. 32–33 in a Han Chinese population
NZ596614A (en) Diagnosis and treatment of alzheimer's disease
Pan et al. Association and cumulative effects of GWAS‐identified genetic variants for nonsyndromic orofacial clefts in a Chinese population
IN2012DN06571A (https=)
van Tilburg et al. A genetic polymorphism that is associated with mitochondrial energy metabolism increases risk of fibromyalgia
Kim et al. The dopamine transporter gene and the impulsivity phenotype in attention deficit hyperactivity disorder: a case-control association study in a Korean sample
Spinks et al. Association of the HOPA12bp allele with a large X‐chromosome haplotype and positive symptom schizophrenia
Reid-Lombardo et al. Inflammation-related gene variants as risk factors for pancreatic cancer
Seyerle et al. Genetic epidemiology: the potential benefits and challenges of using genetic information to improve human health
Prasad et al. Attempts to replicate genetic associations with schizophrenia in a cohort from north India
Huang et al. Association between MSX1 variants and oral clefts in Han Chinese in western China
Giampaoli et al. The SNPs in the human genetic blueprint era
Singh et al. Association of MSX1 799 G> T variant with nonsyndromic cleft lip/palate in South Indian adolescent patients
Lim et al. STXBP6 and B3GNT6 genes are associated with selective IgA deficiency
ATE556324T1 (de) Verwendung von kir-genen zur vorhersage der reaktion auf eine therapie
CN108441560A (zh) 一种位于cep128基因的与放疗引起的放射性脑损伤相关的snp标志物及其应用
Duan et al. Transcriptome outlier analysis implicates schizophrenia susceptibility genes and enriches putatively functional rare genetic variants